<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>School of Life Sciences</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/AF6F1E66-72CA-45CC-85EA-60FCD5F61D57"><gtr:id>AF6F1E66-72CA-45CC-85EA-60FCD5F61D57</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:surname>Girolami</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/CC9ACEE4-E264-4F1C-90DE-48EBC099AB3A"><gtr:id>CC9ACEE4-E264-4F1C-90DE-48EBC099AB3A</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>Peter</gtr:otherNames><gtr:surname>Barrett</gtr:surname><gtr:orcidId>0000-0001-9447-3519</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8897FF0B-AFED-4F39-94A4-EE91ACC194E3"><gtr:id>8897FF0B-AFED-4F39-94A4-EE91ACC194E3</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Burchmore</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FI004599%2F1"><gtr:id>2578B713-CB5C-4179-A7D7-26B72E7D1C16</gtr:id><gtr:title>The Silicon Trypanosome</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/I004599/1</gtr:grantReference><gtr:abstractText>In this proposal we intend to set the foundation for a description of the cellular workings of parasitic protozoa called trypanosomes. Trypanosomes are responsible for the disease sleeping sickness in sub-Saharan Africa. The parasites are transmitted between people by biting tsetse flies. Once injected into the bloodstream they begin to proliferate and eventually invade the brain and central nervous system. Once inside the brain the presence of parasites leads to decreasing neurological function. Patients become depressed and cognitive function breaks down. They eventually become mad, fall into a coma and die. In recent years it has become possible to dissect trypanosomes at the molecular level. We have determined the sequence of their genetic code. We can measure the abundance of the individual proteins that are assembled within the trypanosome's structure. We can also measure the manner by which chemicals are transformed from one to another within the parasite. In short, we have at our disposal the parts list that comprises a trypanosome. We would like to exploit this information to assist in designing drugs that can perturb the parasite's inner workings. However, in order to achieve this, it is not enough to have a simple parts-list of the parasite. We need to understand how those parts assemble and how they interact with one another in order to create this living system, the trypanosome. Systems Biology is a recently emerged discipline that combines high throughput measurements of cellular parts, along with measurements of the dynamics of interactions between those parts and then employs high capacity computational modelling in efforts to describe how cellular constituents combine to create recognisable biological function. An ambition of systems biology is to reconstruct biological systems from descriptions of their component pieces with mathematical descriptions that describe how those pieces interact. Increasingly, models are emerging that describe biological function emerging from combined components of the cell. For several model organisms, including yeast and the bacterium Escherichia coli, models of cellular function are being combined into a project termed 'The silicon cell' which ultimately aims to include all component pieces of a cellular system and to describe the dynamics of the connectivity between them in order to predict how the system behaves as a whole. Profiting from the availability of the full genome sequence and methods to determine how genes are turned on to produce RNA transcripts that are then translated into proteins which ultimately control the flow of life through these cells we propose to generate a 'silicon trypanosome', i.e. we propose to build fully descriptive mathemical models of the flow of information that defines a trypanosome. We will take a bottom up approach, starting with a biochemical pathway, the so-called trypanothione pathway that dictates how well trypanosomes can deal when exposed to oxidative stresses. We have chosen this pathway because a great deal is already known about biochemical parameters of the component proteins, or enzymes, of this pathway. Furthermore the trypanothione pathway links directly through the NADPH generating pentose phosphate pathway to the glycolytic pathway, which consumes the parasite's major energy supply, glucose. A comprehensive mathematical model describing the glycolytic pathway in trypanosomes already exists, hence in a bottom up manner, extending into an adjacent pathway, offers a rational way towards a comprehensive model of the trypanosome. In addition to collecting data on the component pieces of the trypanosome we will alsoimplement a range of novel mathematical techniques to ensure the models we build are testable and robust. Ultimately we aim to use the models to predict the best ways to perturb the parasite's biological make up with the hope of generating new drugs.</gtr:abstractText><gtr:technicalSummary>The aim of this project is the creation of a comprehensive, multi-scale model of trypanosome physiology. Broadly the project can be divided into two phases: Step 1. Building a comprehensive, identifiable, predictive and testable model of trypanosome biology, starting with a detailed analysis of the trypanothione/redox network and the pentose phosphate pathway (including subcellular localization), transcriptomics, and protein abundance and flux. This expands on existing detailed models of various aspects of trypanosome biology, including detailed kinetic models of central metabolism previously published by our group. Step 2. Expansion of pathway knowledge by targeted molecular profiling and statistical ab initio network reconstruction. The following molecular profiling approaches will be employed: Various approaches will be taken to derive accurate quantitative measurements of metabolite levels in trypanosomes. LC-MS, GC-MS, HPLC and NMR, as well as specific bioassays, will all be used to assess metabolites of the polyamine, glutathione and trypanothione pathways. RNAseq will be employed to measure abundance and turnover of transcripts. Enzyme kinetic measurements will be used to acquire additional rate information on parts of the pathway for which information is not available. Mathematical modelling, metabolic control analysis, and statistical inference will be used in the construction of descriptive models across scales. Models will be tested and updated iteratively based on results feeding back through acquisition of new data sets following genetic and pharmacological perturbation of the pathways that assess model veracity.</gtr:technicalSummary><gtr:potentialImpactText>WHO WILL BENEFIT FROM THIS RESEARCH? (a) Biomodellers: This project will involve the development of new statistical methodologies that will enable the Formal characterisation of model uncertainty. These methodologies will be of general utility to all scientists involved in modelling of high throughput datasets in which uncertainty is an inherent feature of the datasets. (b) Systems Biologists: Methods will be developed to integrate multiple 'omic' datasets, along with the dynamics of interactions between transcript, protein and metabolic flux. (c) Trypanosome biologists: Large data sets encompassing all transcripts, proteins and metabolites within a cell will be generated and made available to the trypanosome research community (beyond the pathway upon which we are focusing) (d) Neglected Diseases Drug development agencies: Organisations including the Drugs for Neglected Diseases initiative (DNDi), World Health Organisation (WHO), Consortium for Parasitic Drug Development (CPDD), and other major funding agencies (Bill and Melynda Gates Foundation, Wellcome Trust, European Commission) do not generally employ systems biology in their evaluation of drug targets. We believe that outputs from the project will include new ways of assessing suitability of particular proteins for targets and expect the approach to enter consideration in target evaluation. (e) Human African trypanosomiasis victims and farmers: Although this project will not produce new drugs for HAT directly we believe in the longer term our methodologies will expedite drug target evaluation and ultimately assist in drug development for this neglected tropical disease (and others too as our methods enter other drug development campaigns). Since animal trypanosomiasis is responsible for massive losses to livestock in Africa, the same developments in the drug discovery process will also be relevant to livestock farmers in Africa in the longer term. HOW WILL THEY BENEFIT AND WHAT WILL BE DONE TO ENSURE THAT THEY BENEFIT Biomodellers, Systems Biologists and Trypanosome Biologists will learn of the new methods through conference and publication in International journals, and through data becoming available at community websites e.g. the tritrypDB websites. Software will be available freely from the applicants' wedsites. We will actively demonstrate to the neglected diseases drug development agencies the potential of our methods and demonstrate how software developments can be integrated into existing software (e.g. TDR-targets at the WHO - http://tdrtargets.org/). As we mention above HAT victims will not benefit directly from this project, but from new drug developments that will stem from the methodologies we implement. The same applies to advances in treatment of animal trypanosomiasis.</gtr:potentialImpactText><gtr:fund><gtr:end>2014-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2010-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>626769</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Silicon trypanosome collaboration</gtr:description><gtr:id>1AB8A1DE-F56A-4F2A-9120-3E9EB08940B5</gtr:id><gtr:impact>See publications list from the Silicotryp project BB/1004599/1</gtr:impact><gtr:outcomeId>56dda6dba58923.64790716-1</gtr:outcomeId><gtr:partnerContribution>The Matthews group created multiple trypanosome RNAi strains for analysis of phenotype</gtr:partnerContribution><gtr:piContribution>We have run metabolomics samples for Keith Matthews group</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Emerging paradigms for anti-infective drug design (joint symposuum between the British Society of Parasitology and Royal Socieity of Chemistry)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1BBABEE2-DF4E-4157-8A2C-0224A482A60C</gtr:id><gtr:impact>Symposium to discuss advances in drug development for infectious diseases</gtr:impact><gtr:outcomeId>56dd7ca6c3ac07.84140989</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.lshtm.ac.uk/newsevents/events/2012/09/emerging-paradigms-in-anti-infective-drug-design</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Symposium: Glasgow Encounters with Tropical Disease</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8FC4C0BB-9008-4DF0-9738-A709B5D9FE4E</gtr:id><gtr:impact>We held a symposium with myself and seven other experts in tropical diseases to discuss these diseases from the contemporary point of view, but in the context of the rich history of research into these diseases from the perspective of Glasgow University.</gtr:impact><gtr:outcomeId>56d8573a7612c5.47209211</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.gla.ac.uk/researchinstitutes/iii/wtcmp/aboutthewtcmp/wtcmpnews/headline_439330_en.html</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>David Livingstone and the Scottish Encounter with Tropical Disease</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1C345BE8-8DF0-40B6-962E-5ECC41447217</gtr:id><gtr:impact>A day long symposium where experts in tropical diseases from the World Health Organisation, Bill and Melinda Gates Foundation, several UK-based and International institutes joined experts from the University of Glasgow to discuss tropical diseases and their enduring impact, from the perspective of the extraordinary discoveries of Dr Livingstone (an alumnus of the University of Glasgow - whose bicentenary was celebrated this year).</gtr:impact><gtr:outcomeId>56dd421e6bd384.52600905</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.gla.ac.uk/events/?action=details&amp;id=6333</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Metabolomics Society Meeting, Glasgow 2013</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>64E08E76-C4D8-40EE-9B2C-19193B8EF93A</gtr:id><gtr:impact>The annual meeting of the Metabolomics Society held in Glasgow to disseminate updates in Metabolomics research</gtr:impact><gtr:outcomeId>56dd7b4b6db0a0.21167763</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.metabolomics2013.org/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Regular contributor to Newstatesman magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F25EF45A-0186-43EA-A32D-1FB1E5D14FF9</gtr:id><gtr:impact>I write about science regularly for the New Statesman magazine.</gtr:impact><gtr:outcomeId>56dd77f0b877b3.94536324</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.newstatesman.com/writers/313154</gtr:url><gtr:year>Pre-2006,2006,2007,2008,</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The Silicon trypanosome project involved a multinational, multipartner consortium aiming to better understand the metabolism of the parasite Trypanosoma brucei by combining computational modelling at different levels to the collection of large datasets in transcriptomics, proteomics and metabolomics. In Glasgow we focused on collecting metabolomics datasets that were able to provide quantitative information to both feed into and test computational models of metabolism. Of particular importance was the implementation of advanced statistical methodoliges enabling the handling of uncertainty in development of dymanic models of metabolism derived from kinetic measurements of individual enzymes. Models have been published, along with primary datasets with their interpretation.</gtr:description><gtr:exploitationPathways>The concepts introduced with regard to introducing the concept of uncertainty into modelling of metabolism will be applied increasingly to other biological systems. In determining how central carbon metabolism operates in trypanosomes the models we have produced also point to novel drug targets and point to ways to develop new drugs for African trypanosomiasis.</gtr:exploitationPathways><gtr:id>7402F6CE-474A-430A-AC9E-F7E42ECC1FF1</gtr:id><gtr:outcomeId>56dd7fc04cef60.89636583</gtr:outcomeId><gtr:sectors><gtr:sector>Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.sysmo.net/index.php?index=164</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>A kinetic model of the pentose phosphate pathway was created and merged with the T. brucei glycolysis model</gtr:description><gtr:id>022AE4B1-C165-4D5F-A96A-FD506B23EDEB</gtr:id><gtr:impact>Previously the glycolysis model in T. brucei was considered among the best dynamic simulations of a metabolic pathway. In showing that bound phsophate leaves the cellular compartment in which glycolsysi resides in trypanosomes, once the pentose phosphate pathway was added, we were able to ascertain the need to consider new reactions of phosphate balance.</gtr:impact><gtr:outcomeId>56ddab922ec6d9.55473703</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Pentose phosphate pathway added to Glycolysis in T. brucei</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>https://seek.sysmo-db.org/publications/224</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>This model adds uncertainty, in the form of using ranges of values rather than singe values to describe individual enzye reactions in the T. brucei model of glycolysis.</gtr:description><gtr:id>42994C9F-1A58-467E-8B80-CB19F08B63DC</gtr:id><gtr:impact>We have not been able to ascertain how widely the modelling method is taken up yet.</gtr:impact><gtr:outcomeId>56ddaa456dba85.12449982</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Updated glycolysis model with uncertainty</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>https://seek.sysmo-db.org/models/107</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We designed a new culture medium for cultivation of bloodstream form trypanosomes that allows better assessment of drug activity in vivo.</gtr:description><gtr:id>BE44DEDF-B49F-4251-BF69-824D78807780</gtr:id><gtr:impact>The new culture medium is not only cheaper (being dependent on many fewer nutrients than its predecessors) and provides cleaner metabolomics data (since the high ebundance of many nutrients in classical medium can mask events within the cells, it also allows detection of activity of various drugs (e.g. antifolates) that appear inactive in classical medium due to over abundance of folate.</gtr:impact><gtr:outcomeId>56dd88f116e578.81347011</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New in vitro culture medium for African trypanosomes</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>FBFCA2AD-CF36-4E49-98A1-15E20306B3E0</gtr:id><gtr:title>Stable isotope-assisted metabolomics for network-wide metabolic pathway elucidation.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc699723df221d3566b40e13d4190abe"><gtr:id>dc699723df221d3566b40e13d4190abe</gtr:id><gtr:otherNames>Creek DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>56dd26c4932206.00810027</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFAC16B2-5E40-4D73-A2B2-2D5088C66ECC</gtr:id><gtr:title>IDEOM: an Excel interface for analysis of LC-MS-based metabolomics data.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc699723df221d3566b40e13d4190abe"><gtr:id>dc699723df221d3566b40e13d4190abe</gtr:id><gtr:otherNames>Creek DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>56dd26c52e7cf2.25979175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75CA97BB-379C-43C1-86B9-3C813B555AB4</gtr:id><gtr:title>Trypanosoma brucei: meet the system.</gtr:title><gtr:parentPublicationTitle>Current opinion in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/027d5a2ae19ce7899ff9624b7c5356a1"><gtr:id>027d5a2ae19ce7899ff9624b7c5356a1</gtr:id><gtr:otherNames>Achcar F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1369-5274</gtr:issn><gtr:outcomeId>56dd26c1b45933.05588541</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F2B44E2-E3DB-44C7-B6A9-230D7C9EC3F0</gtr:id><gtr:title>The silicon trypanosome: a test case of iterative model extension in systems biology.</gtr:title><gtr:parentPublicationTitle>Advances in microbial physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/027d5a2ae19ce7899ff9624b7c5356a1"><gtr:id>027d5a2ae19ce7899ff9624b7c5356a1</gtr:id><gtr:otherNames>Achcar F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0065-2911</gtr:issn><gtr:outcomeId>56dd26c2c32f07.66162323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F12D1720-3DCB-4536-8027-81768962F0EA</gtr:id><gtr:title>Metabolomic analysis of trypanosomatid protozoa.</gtr:title><gtr:parentPublicationTitle>Molecular and biochemical parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc699723df221d3566b40e13d4190abe"><gtr:id>dc699723df221d3566b40e13d4190abe</gtr:id><gtr:otherNames>Creek DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0166-6851</gtr:issn><gtr:outcomeId>56dd26c5499cd3.24280838</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F59E6E23-72A5-48FD-A469-3E39D487AB98</gtr:id><gtr:title>LC-MS-based absolute metabolite quantification: application to metabolic flux measurement in trypanosomes.</gtr:title><gtr:parentPublicationTitle>Metabolomics : Official journal of the Metabolomic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2188e89405bf6b4afb9f9f1a390482d"><gtr:id>c2188e89405bf6b4afb9f9f1a390482d</gtr:id><gtr:otherNames>Kim DH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1573-3882</gtr:issn><gtr:outcomeId>5675f16122e08</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>257CC6E9-4DD4-40B3-B72A-AA2A768FB946</gtr:id><gtr:title>Metabolomic systems biology of trypanosomes.</gtr:title><gtr:parentPublicationTitle>Parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55ba8c0883c0b61ad823b3dffc3d6891"><gtr:id>55ba8c0883c0b61ad823b3dffc3d6891</gtr:id><gtr:otherNames>Barrett MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0031-1820</gtr:issn><gtr:outcomeId>doi_55f94d94d4ea7224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCB3236F-2D84-434B-906A-09D98EFF4904</gtr:id><gtr:title>Probing the metabolic network in bloodstream-form Trypanosoma brucei using untargeted metabolomics with stable isotope labelled glucose.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc699723df221d3566b40e13d4190abe"><gtr:id>dc699723df221d3566b40e13d4190abe</gtr:id><gtr:otherNames>Creek DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56dd26c0f15c78.11712147</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90CC44F4-C133-452A-99AA-4F5A294B73F6</gtr:id><gtr:title>Metabolomics guides rational development of a simplified cell culture medium for drug screening against Trypanosoma brucei.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc699723df221d3566b40e13d4190abe"><gtr:id>dc699723df221d3566b40e13d4190abe</gtr:id><gtr:otherNames>Creek DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>56dd26c3c978a8.34803360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7184905-E9C1-49F2-A531-249BAD4643DF</gtr:id><gtr:title>Use of reconstituted metabolic networks to assist in metabolomic data visualization and mining.</gtr:title><gtr:parentPublicationTitle>Metabolomics : Official journal of the Metabolomic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a18b442dd715febcb189884d2f3e83e"><gtr:id>1a18b442dd715febcb189884d2f3e83e</gtr:id><gtr:otherNames>Jourdan F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1573-3882</gtr:issn><gtr:outcomeId>doi_55f94d94d4e215b0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B301983-134B-489F-8E1F-772BEA7890EC</gtr:id><gtr:title>The silicon trypanosome.</gtr:title><gtr:parentPublicationTitle>Parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a09131f355ccdae12954eef397fdea0"><gtr:id>3a09131f355ccdae12954eef397fdea0</gtr:id><gtr:otherNames>Bakker BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0031-1820</gtr:issn><gtr:outcomeId>doi_55f94d94d4f46493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8894284-7418-48CB-BAB4-F781F88B5770</gtr:id><gtr:title>Explicit consideration of topological and parameter uncertainty gives new insights into a well-established model of glycolysis.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/027d5a2ae19ce7899ff9624b7c5356a1"><gtr:id>027d5a2ae19ce7899ff9624b7c5356a1</gtr:id><gtr:otherNames>Achcar F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>56dd26c3806168.51059524</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9B18D86-3E6D-485C-AFD8-9B0C1CEA7DDA</gtr:id><gtr:title>Dynamic modelling under uncertainty: the case of Trypanosoma brucei energy metabolism.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/027d5a2ae19ce7899ff9624b7c5356a1"><gtr:id>027d5a2ae19ce7899ff9624b7c5356a1</gtr:id><gtr:otherNames>Achcar F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>doi_55f94d94d4fd97e6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E40687A-EB71-4DA7-81DE-EA971EFDC2EF</gtr:id><gtr:title>Toward global metabolomics analysis with hydrophilic interaction liquid chromatography-mass spectrometry: improved metabolite identification by retention time prediction.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc699723df221d3566b40e13d4190abe"><gtr:id>dc699723df221d3566b40e13d4190abe</gtr:id><gtr:otherNames>Creek DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>56dd26c619e559.49617781</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/I004599/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>